BNTC

Benitec Biopharma
$11.58
+$0.11 (+0.96%)Jul 27, 2026
3.1FairMoatMint rating

MoatMint rates Benitec Biopharma (BNTC) 3.1 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 0.6 out of 10.

Key metrics

The numbers that frame BNTC today
Market cap
$397.82M
P/E (TTM)
-8.1
EV / FCF
-10.8
ROIC
-39,873.3%
Div yield
0%
Debt / equity
0.0
52wk Low
$9.85
52wk High
$16.76

BNTC stock rating

How BNTC scores on quality, value, growth, momentum and financial health
3.1out of 10
Fair overallFair business, expensive priceTop 69% of ~5,000 US stocks
QualityPoor0.6/10
GrowthGood6.7/10
MomentumNeutral4.8/10
ValuePoor1.9/10
Financial HealthGreat9.4/10

Growth

Revenue and earnings trend for BNTC
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about BNTC
Is Benitec Biopharma a good buy?
No. Benitec Biopharma has poor quality and mixed momentum. The setup is weak overall. Growth looks strong, which supports the long-term business case, but that is not enough to offset the weak setup. We think Benitec Biopharma is selling at a very high price.
What is the market capitalization of BNTC?
Benitec Biopharma's market capitalization is $397.82M.
What is the P/E ratio for BNTC stock?
Benitec Biopharma's current P/E ratio is -8.1.
What is the 52-week high for BNTC stock?
The 52-week high for Benitec Biopharma is $16.76. The current close of $11.58 is 30.9% below that high.
What is the 52-week low for BNTC stock?
The 52-week low for Benitec Biopharma is $9.85. The current close of $11.58 is 17.6% above that low.
Does BNTC stock pay dividends?
Benitec Biopharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BNTC?
Benitec Biopharma's Debt / Equity ratio is 0.01.